Interestingly, triptolide is found to enhance the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in pancreatic cancer cells by autophagy activation through Pumilio RNA-binding family member 1 (PUM1) downregulation, suggesting a potential strategy to increase tumor sensitivity to TRAIL [995]. Here, PUM1 is linked to familial pancreatic carcinoma.